Literature DB >> 11478378

Docosahexaenoic acid accumulation in the prenatal brain: prooxidant and antioxidant features.

E Yavin1, S Glozman, P Green.   

Abstract

Docosahexaenoic acid (DHA; 22:6n-3) is the major polyunsaturated fatty acid (FA) in the adult rat brain and it accumulates significantly more than any other FA prior to birth. Under normal nutritional conditions, fetal-brain DHA accumulation is substantial, with a "DHA accretion spurt" being demonstrated in the last period of gestation. Under stress conditions, this spurt may be harmful owing to an increase in multiple double-bond targets for lipid peroxidation. The "DHA accretion spurt" is supported by the maternal supply of DHA or its precursor. Under maternal dietary n-3 FA deficiency, DHA content in the fetal brain can be restored by direct intraamniotic injection of mM concentrations of ethyl-DHA (Et-DHA). This approach may hold a potential advantage in the event of maternal-fetal insufficiency, a stress that may cause intrauterine growth retardation. It also revealed a potential beneficial effect after in utero ischemic stress; brain slices from Et-DHA-treated fetuses formed less oxidation products, as detected by thiobarbituric acid (TBA), compared to controls. Furthermore, brain-lipid extracts from Et-DHA but not ethyl-oleate treated fetuses, exhibited hydroxyl radical scavenging activity, as demonstrated by electron spin-resonance technique. Part of the beneficial effect of Et-DHA administration on the fetal brain may be attributed to enhanced free-radical scavenging capability, a phenomenon not directly related to vitamin E or lipid-soluble antioxidant levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478378     DOI: 10.1385/JMN:16:2-3:229

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Ischaemia of the preterm brain.

Authors:  G Greisen
Journal:  Biol Neonate       Date:  1992

2.  Spin-trapping methods for detecting superoxide and hydroxyl free radicals in vitro and in vivo.

Authors:  G R Buettner; R P Mason
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders.

Authors:  M Martínez; E Vázquez; M T García-Silva; J Manzanares; J M Bertran; F Castelló; I Mougan
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

4.  Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat.

Authors:  M Nakashima; M Niwa; T Iwai; T Uematsu
Journal:  Free Radic Biol Med       Date:  1999-03       Impact factor: 7.376

5.  Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain: a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid.

Authors:  S A Moore
Journal:  World Rev Nutr Diet       Date:  1994       Impact factor: 0.575

6.  Modest hypothermia preserves cerebral energy metabolism during hypoxia-ischemia and correlates with brain damage: a 31P nuclear magnetic resonance study in unanesthetized neonatal rats.

Authors:  G D Williams; B J Dardzinski; A R Buckalew; M B Smith
Journal:  Pediatr Res       Date:  1997-11       Impact factor: 3.756

7.  Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.

Authors:  G E Billman; H Hallaq; A Leaf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood.

Authors:  L J Hatam; H J Kayden
Journal:  J Lipid Res       Date:  1979-07       Impact factor: 5.922

9.  Autoregulation of cerebral blood flow: influence of local brain development and postnatal age.

Authors:  U I Tuor; D Grewal
Journal:  Am J Physiol       Date:  1994-12

10.  Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo.

Authors:  P Green; E Yavin
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

View more
  5 in total

1.  Effects of controlled cortical impact and docosahexaenoic acid on rat pup fatty acid profiles.

Authors:  Michelle E Schober; Daniela F Requena; J Alan Maschek; James Cox; Leonardo Parra; Alyssa Lolofie
Journal:  Behav Brain Res       Date:  2019-10-13       Impact factor: 3.332

2.  Long-term effects of LCPUFA supplementation on childhood cognitive outcomes.

Authors:  John Colombo; Susan E Carlson; Carol L Cheatham; D Jill Shaddy; Elizabeth H Kerling; Jocelynn M Thodosoff; Kathleen M Gustafson; Caitlin Brez
Journal:  Am J Clin Nutr       Date:  2013-06-26       Impact factor: 7.045

3.  Maternal dietary DHA supplementation to improve inflammatory outcomes in the preterm infant.

Authors:  Christina J Valentine
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 4.  Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

Authors:  Grace Y Sun; Agnes Simonyi; Kevin L Fritsche; Dennis Y Chuang; Mark Hannink; Zezong Gu; C Michael Greenlief; Jeffrey K Yao; James C Lee; David Q Beversdorf
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-03-10       Impact factor: 3.015

5.  Free Radical Chain Reactions and Polyunsaturated Fatty Acids in Brain Lipids.

Authors:  Sharon C W Ng; Ran Furman; Paul H Axelsen; Mikhail S Shchepinov
Journal:  ACS Omega       Date:  2022-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.